Back to Agenda
Cutting Through the Hype: How are AI and Emerging Technologies Accelerating Progress Now?
Session Chair(s)
Jessica Federer, MPH
Board Member
Angelini Ventures, United States
We’ve all heard the hype around emerging technologies and what it means for our industry, but when it comes down to adding value on the ground today, what advancements are actually making a difference in drug discovery, development, and distribution?
Learning Objective : Describe and explain the advancements in data analytics and emerging technologies that are adding value to biopharma companies today.
Speaker(s)
Panelist
Cindy Hoots
AstraZeneca, United States
Chief Digital Officer and Chief Information Officer
Have an account?